Cargando…
Antitumor Activity of Curcumin in Glioblastoma
Current standard-of-care treatment for glioblastoma, the most common malignant primary central nervous system (CNS) tumor, consists of surgical resection followed by adjuvant chemotherapy and radiation (Stupp protocol), providing an overall median survival of 15 months. With additional treatment usi...
Autores principales: | Walker, Blake C., Mittal, Sandeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763573/ https://www.ncbi.nlm.nih.gov/pubmed/33322413 http://dx.doi.org/10.3390/ijms21249435 |
Ejemplares similares
-
TB-4 Antitumor effects of a novel curcumin derivative curcumin monoglucuronide on glioblastoma cells in vitro and in vivo
por: Fujii, Takashi, et al.
Publicado: (2021) -
Polychemotherapy with Curcumin and Doxorubicin via Biological Nanoplatforms: Enhancing Antitumor Activity
por: Ashrafizadeh, Milad, et al.
Publicado: (2020) -
Anticancer Mechanism of Curcumin on Human Glioblastoma
por: Wong, Shu Chyi, et al.
Publicado: (2021) -
Therapeutic Potential of Curcumin for the Treatment of Brain Tumors
por: Klinger, Neil V., et al.
Publicado: (2016) -
Antitumoral Activities of Curcumin and Recent Advances to ImProve Its Oral Bioavailability
por: Nocito, Marta Claudia, et al.
Publicado: (2021)